Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon
- 26 April 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (19), 8772-8777
- https://doi.org/10.1073/pnas.0905745107
Abstract
Crohn's disease (CD), a major form of human inflammatory bowel disease, is characterized by primary immunodeficiencies. The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) is essential for intestinal homeostasis in response to both dietary- and microbiota-derived signals. Its role in host defense remains unknown, however. We show that PPARγ functions as an antimicrobial factor by maintaining constitutive epithelial expression of a subset of β-defensin in the colon, which includes mDefB10 in mice and DEFB1 in humans. Colonic mucosa of Pparγ mutant animals shows defective killing of several major components of the intestinal microbiota, including Candida albicans, Bacteroides fragilis, Enterococcus faecalis, and Escherichia coli. Neutralization of the colicidal activity using an anti-mDefB10 blocking antibody was effective in a PPARγ-dependent manner. A functional promoter variant that is required for DEFB1 expression confers strong protection against Crohn's colitis and ileocolitis (odds ratio, 0.559; P = 0.018). Consistently, colonic involvement in CD is specifically linked to reduced expression of DEFB1 independent of inflammation. These findings support the development of PPARγ-targeting therapeutic and/or nutritional approaches to prevent colonic inflammation by restoring antimicrobial immunity in CD.Keywords
This publication has 26 references indexed in Scilit:
- Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple β-defensins in gingival keratinocytesBMC Oral Health, 2009
- Colorectal Cancer Expression of Peroxisome Proliferator-Activated Receptor γ (PPARG, PPARgamma) Is Associated With Good PrognosisGastroenterology, 2009
- Genetic Variants of Wnt Transcription Factor TCF-4 (TCF7L2) Putative Promoter Region Are Associated with Small Intestinal Crohn's DiseasePLOS ONE, 2009
- Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasisNature, 2008
- Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's diseaseMucosal Immunology, 2008
- Interaction between seroreactivity to microbial antigens and genetics in Crohn’s disease: is there a role for defensins?Tissue Antigens, 2008
- Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled TrialGastroenterology, 2008
- Reduced mucosal antimicrobial activity in Crohn's disease of the colonGut, 2007
- PPAR as a new therapeutic target in inflammatory bowel diseasesGut, 2006
- Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.JCI Insight, 1998